Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7897146 Treatment using herpes simplex virus

Patent 7897146 was granted and assigned to Crusade Laboratories Ltd. on March, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Crusade Laboratories Ltd.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Guy Michael Gary Hamilton0

Susanne Moira Brown0

Date of Patent

March 1, 2011

0

Patent Application Number

120653500

Date Filed

August 30, 2006

0

Patent Citations Received

US Patent 11920156 Engineered natural killer (NK) cells and compositions and methods thereof

0

US Patent 11834490 CD112 variant immunomodulatory proteins and uses thereof

0

US Patent 12012600 Engineered immunostimulatory bacterial strains and uses thereof

0

US Patent 12110339 ICOS ligand variant immunomodulatory proteins and uses thereof

0

US Patent 12065476 PD-1 variant immunomodulatory proteins and uses thereof

0

US Patent 12024709 Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment

0

Patent Primary Examiner

Peter Paras, Jr.

0

Patent abstract

The use of Herpes Simplex Virus (HSV) in the treatment of tumour by extratumoural administration of HSV, and the use of HSV in treatment of tumour by combination therapy with a pharmaceutical wherein the HSV and/or pharmaceutical is administered at an extratumoural location, is disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7897146 Treatment using herpes simplex virus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.